BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31068244)

  • 1. Relationships between Cytokine Levels and Disease Parameters during the Development of a Collagen-induced Arthritis Model in Cynomolgus Macaques (
    Choi EW; Kim S
    Comp Med; 2019 May; 69(3):228-239. PubMed ID: 31068244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle wasting associated with pathologic change is a risk factor for the exacerbation of joint swelling in collagen-induced arthritis in cynomolgus monkeys.
    Horai N; Nagaoka T; Higuchi I; Kasai H; Yoshioka T; Umekita Y; Fukuzaki K; Nagata R; Miyata A; Abeyama K
    BMC Musculoskelet Disord; 2013 Jul; 14():205. PubMed ID: 23834772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The establishment of a rheumatoid arthritis primate model in Macaca fascicularis.
    Na HS; Lee SY; Min HK; Park WJ; Lee JH; Cho KH; Hong SH; Kim DH; Jhun J; Choi JW; Kim SM; Kwok SK; Cho ML; Park SH
    J Transl Med; 2020 Jun; 18(1):264. PubMed ID: 32605610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia in monkey collagen-induced arthritis is correlated with serum IL-6, but not TNFalpha.
    Uchiyama Y; Koike N; Mihara M
    Rheumatol Int; 2008 Jul; 28(9):879-83. PubMed ID: 18309490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.
    Zimmerman DH; Taylor P; Bendele A; Carambula R; Duzant Y; Lowe V; O'Neill SP; Talor E; Rosenthal KS
    Int Immunopharmacol; 2010 Apr; 10(4):412-21. PubMed ID: 20074669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of rats with homologous type XI collagen leads to chronic and relapsing arthritis with different genetics and joint pathology than arthritis induced with homologous type II collagen.
    Lu S; Carlsen S; Hansson AS; Holmdahl R
    J Autoimmun; 2002 May; 18(3):199-211. PubMed ID: 12126633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-3 levels in relation to disease activity and radiological progression in rheumatoid arthritis.
    Tuncer T; Kaya A; Gulkesen A; Kal GA; Kaman D; Akgol G
    Adv Clin Exp Med; 2019 May; 28(5):665-670. PubMed ID: 30740946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers.
    Young-Min S; Cawston T; Marshall N; Coady D; Christgau S; Saxne T; Robins S; Griffiths I
    Arthritis Rheum; 2007 Oct; 56(10):3236-47. PubMed ID: 17907159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of peripheral CD14low monocytes in the development of collagen-induced arthritis in cynomolgus monkeys (Macaca fascicularis).
    Terao K; Fujimoto K; Shimozuru Y; Nagai Y; Yoshikawa Y
    Exp Anim; 2001 Jan; 50(1):9-18. PubMed ID: 11326430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torilin ameliorates type II collagen-induced arthritis in mouse model of rheumatoid arthritis.
    Endale M; Lee WM; Kwak YS; Kim NM; Kim BK; Kim SH; Cho J; Kim S; Park SC; Yun BS; Ko D; Rhee M
    Int Immunopharmacol; 2013 Jun; 16(2):232-42. PubMed ID: 23623942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis.
    Post AM; Katsikis PD; Tait JF; Geaghan SM; Strauss HW; Blankenberg FG
    J Nucl Med; 2002 Oct; 43(10):1359-65. PubMed ID: 12368374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-linked differences in susceptibility of cynomolgus monkeys to type II collagen-induced arthritis. Evidence that epitope-specific immune suppression is involved in the regulation of type II collagen autoantibody formation.
    Terato K; Arai H; Shimozuru Y; Fukuda T; Tanaka H; Watanabe H; Nagai Y; Fujimoto K; Okubo F; Cho F
    Arthritis Rheum; 1989 Jun; 32(6):748-58. PubMed ID: 2472147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of the total lignans from Vitex negundo seeds on collagen-induced arthritis in rats.
    Jing R; Ban Y; Xu W; Nian H; Guo Y; Geng Y; Zang Y; Zheng C
    Phytomedicine; 2019 May; 58():152825. PubMed ID: 30831463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
    Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
    BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorates joint swelling in established monkey collagen-induced arthritis.
    Uchiyama Y; Yorozu K; Hashizume M; Moriya Y; Mihara M
    Biol Pharm Bull; 2008 Jun; 31(6):1159-63. PubMed ID: 18520048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone.
    Garnero P; Thompson E; Woodworth T; Smolen JS
    Arthritis Rheum; 2010 Jan; 62(1):33-43. PubMed ID: 20039425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapy of Mesenchymal Stromal Cells and Interleukin-4 Attenuates Rheumatoid Arthritis in a Collagen-Induced Murine Model.
    Haikal SM; Abdeltawab NF; Rashed LA; Abd El-Galil TI; Elmalt HA; Amin MA
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.